Loring Wolcott & Coolidge Fiduciary Advisors’s RenaissanceRe RNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,960
Closed -$1.2M 583
2026
Q1
$1.2M Hold
3,960
0.01% 149
2025
Q4
$1.09M Hold
3,960
0.01% 158
2025
Q3
$963K Buy
+3,960
New +$959K 0.01% 172
2025
Q2
Sell
-1
Closed -$240 555
2025
Q1
$240 Hold
1
﹤0.01% 555
2024
Q4
$263 Sell
1
-8
-89% -$2.15K ﹤0.01% 554
2024
Q3
$2.45K Buy
+9
New +$2.17K ﹤0.01% 542
2022
Q1
Sell
-150
Closed -$25K 702
2021
Q4
$25K Hold
150
﹤0.01% 524
2021
Q3
$21K Hold
150
﹤0.01% 523
2021
Q2
$22K Buy
+150
New +$23.9K ﹤0.01% 536
2021
Q1
Sell
-300
Closed -$50K 612
2020
Q4
$50K Sell
300
-50
-14% -$8.49K ﹤0.01% 431
2020
Q3
$59K Sell
350
-50
-13% -$8.84K ﹤0.01% 379
2020
Q2
$68K Hold
400
﹤0.01% 352
2020
Q1
$60K Sell
400
-150
-27% -$26.7K ﹤0.01% 357
2019
Q4
$108K Hold
550
﹤0.01% 337
2019
Q3
$106K Sell
550
-50
-8% -$9.31K ﹤0.01% 333
2019
Q2
$107K Buy
+600
New +$98.6K ﹤0.01% 330

Other funds holding RNR

Loring Wolcott & Coolidge Fiduciary Advisors's RNR Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of RenaissanceRe (RNR) in Q2 2026, closing a stake of 3,960 shares — an estimated $1.2M sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in RNR in Q2 2019 and held it in 16 quarters. The position peaked at $1.2M in Q1 2026. 571 funds tracked by Wall St. Rank hold RNR as of Q2 2026.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining RenaissanceRe position as of Q2 2026 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 3,960 RenaissanceRe shares in Q2 2026, an estimated $1.2M.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in RenaissanceRe in Q2 2019 and held it in 16 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's RenaissanceRe position peaked at $1.2M in Q1 2026.
  • 571 funds tracked by Wall St. Rank held RenaissanceRe as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.